IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Ventyx Biosciences Inc (VTYX)

CUSIP: 92332V107 | NYSE | Healthcare · Biotechnology | Small Cap | 369 institutional holders

Quarters

Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13D/ASubramaniam Somu00.0%Fell below 5%Mar 4, 2026No 13F filer matched
13D/ARaju Mohan4,387,6826.0%+5,322Jan 7, 2026

Institutional Holders — Q1 2026

IFP Advisors, Inc1,500
0.0% of portfolio›$21.0K
Vanguard Group Inc0
0.0% of portfolio›$0
StyleTurnoverLocationFiled
IFP Advisors, Inc
1,500$21.0K0.0%GrowthLowTampa, FL2026-04-13
Vanguard Group Inc
0$00.0%N/AN/AValley Forge, PA2026-05-14
No 13F filer matched
13D/ASubramaniam Somu0
0.0% of class · Mar 4, 2026Fell below 5%
No 13F filer matched
13D/ARaju Mohan4,387,682
6.0% of class · Jan 7, 2026+5,322
No 13F filer matched